Greg Shelley

714 total citations
15 papers, 467 citations indexed

About

Greg Shelley is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Greg Shelley has authored 15 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Greg Shelley's work include Prostate Cancer Treatment and Research (8 papers), Bone health and treatments (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Greg Shelley is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Bone health and treatments (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Greg Shelley collaborates with scholars based in United States, China and Japan. Greg Shelley's co-authors include Alan Booth, Allan Mazur, G. D. Tharp, R. J. Kittok, Evan T. Keller, Jinlu Dai, Zhi Yao, Atsushi Mizokami, Yuan Jiang and Hui Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Oncogene.

In The Last Decade

Greg Shelley

13 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Greg Shelley United States	8	200	107	90	81	74	15	467
Michael Elias United States	10	106 0.5×	75 0.7×	132 1.5×	36 0.4×	54 0.7×	17	505
Magdalena Jurkiewicz United States	11	66 0.3×	42 0.4×	73 0.8×	131 1.6×	53 0.7×	22	513
Yaniv Stein Israel	8	61 0.3×	91 0.9×	181 2.0×	28 0.3×	8 0.1×	9	630
Sri N. Shekar Australia	15	79 0.4×	76 0.7×	120 1.3×	37 0.5×	4 0.1×	22	824
Norma Morrison United Kingdom	15	230 1.1×	47 0.4×	236 2.6×	17 0.2×	59 0.8×	24	794
Shengru Guo United States	14	103 0.5×	132 1.2×	328 3.6×	45 0.6×	16 0.2×	27	797
Jun Moriya Japan	17	359 1.8×	71 0.7×	132 1.5×	20 0.2×	5 0.1×	52	835
K. Kidd United States	12	60 0.3×	50 0.5×	356 4.0×	15 0.2×	16 0.2×	16	972
Frédérique Morizot France	15	138 0.7×	52 0.5×	154 1.7×	23 0.3×	12 0.2×	32	918
Aaron R. Wolen United States	15	35 0.2×	58 0.5×	316 3.5×	31 0.4×	10 0.1×	21	745

Countries citing papers authored by Greg Shelley

Since Specialization

Citations

This map shows the geographic impact of Greg Shelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Shelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Shelley more than expected).

Fields of papers citing papers by Greg Shelley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Shelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Shelley. The network helps show where Greg Shelley may publish in the future.

Co-authorship network of co-authors of Greg Shelley

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Shelley. A scholar is included among the top collaborators of Greg Shelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Shelley. Greg Shelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Shelley, Greg, et al.. (2025). A spatiotemporal atlas of orchiectomy-induced androgen deprivation-mediated modulation of cellular composition and gene expression in the mouse prostate. Neoplasia. 69. 101230–101230.

Cho, Hanbyul, Jean C. Tien, Rahul Mannan, et al.. (2025). Cellular cartography reveals mouse prostate organization and determinants of castration resistance. Proceedings of the National Academy of Sciences. 122(35). e2427116122–e2427116122. 1 indexed citations

Dong, Liang, Cong Hu, Zehua Ma, et al.. (2024). Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical Oncology. 41(7). 169–169. 8 indexed citations

The, Stephanie, et al.. (2023). Integration of Single-Cell RNA-Sequencing and Network Analysis to Investigate Mechanisms of Drug Resistance. Methods in molecular biology. 2660. 85–94. 2 indexed citations

Barbosa, Mayara Garcia de Mattos, Hui Liu, Greg Shelley, et al.. (2021). IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity. JCI Insight. 6(9). 8 indexed citations

Escara‐Wilke, June, Jinlu Dai, Greg Shelley, et al.. (2021). Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate Cancer. BMC Cancer. 21(1). 1316–1316. 10 indexed citations

Shelley, Greg, Jinlu Dai, Jill M. Keller, & Evan T. Keller. (2021). Pheno-SELEX: Engineering Anti-Metastatic Aptamers through Targeting the Invasive Phenotype Using Systemic Evolution of Ligands by Exponential Enrichment. Bioengineering. 8(12). 212–212. 4 indexed citations

Shelley, Greg, et al.. (2020). Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells. Molecular Cancer Research. 18(9). 1290–1301. 33 indexed citations

Smith, David C., Stephanie Daignault‐Newton, Petros Grivas, et al.. (2020). Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. 18(4). 332–339.e2. 5 indexed citations

10.

Jiang, Yuan, Jinlu Dai, Zhi Yao, Greg Shelley, & Evan T. Keller. (2017). Abituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression. Molecular Cancer Research. 15(7). 875–883. 27 indexed citations

11.

Yu, Chunyan, Jill M. Keller, Joseph L. Sottnik, et al.. (2013). Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer. Oncogene. 33(19). 2464–2477. 19 indexed citations

12.

Grivas, Petros, Stephanie Daignault, Kathleen A. Cooney, et al.. (2013). A phase II trial of cabozantinib (Cabo) in patients (pts) with castrate-resistant prostate cancer (CRPC) metastatic to bone (NCT01428219).. Journal of Clinical Oncology. 31(15_suppl). TPS5094–TPS5094. 1 indexed citations

13.

Shelley, Greg, Xinshu Zhang, Jill M. Keller, & Evan T. Keller. (2010). Novel application of aptamer selection (pheno-SELEX) to target the invasive phenotype successfully creates anti-metastatic aptamers. Bone. 48(1). S38–S38.

14.

Kenton, Paul, Robert Darby, Greg Shelley, & John Draper. (2000). A PR‐5 gene promoter from Asparagus officinalis (AoPRT‐L) is not induced by abiotic stress, but is activated around sites of pathogen challenge and by salicylate in transgenic tobacco. Molecular Plant Pathology. 1(6). 367–378. 12 indexed citations

15.

Booth, Alan, Greg Shelley, Allan Mazur, G. D. Tharp, & R. J. Kittok. (1989). Testosterone, and winning and losing in human competition. Hormones and Behavior. 23(4). 556–571. 337 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact